FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016366089> ?p ?o ?g. }

• W2016366089 endingPage "1509" @default.
• W2016366089 startingPage "1498" @default.
• W2016366089 abstract "We report the first large renal biopsy-based clinicopathologic study on obesity-related glomerulopathy.Obesity was defined as body mass index (BMI)> 30 kg/m2. Obesity-related glomerulopathy (ORG) was defined morphologically as focal segmental glomerulosclerosis and glomerulomegaly (O-FSGS; N = 57) or glomerulomegaly alone (O-GM; N = 14).Review of 6818 native renal biopsies received from 1986 to 2000 revealed a progressive increase in biopsy incidence of ORG from 0.2% in 1986-1990 to 2.0% in 1996-2000 (P = 0.0001). Mean BMI in ORG was 41.7 (range 30.9 to 62.7). Indications for renal biopsy included proteinuria (N = 40) or proteinuria and renal insufficiency (N = 31). Seventy-one patients with ORG were compared to 50 patients with idiopathic FSGS (I-FSGS). Patients with ORG were older (mean 42.9 vs. 32.6 years, P < 0.001) and more often Caucasian (75% vs. 52%; P = 0.003). ORG patients had a lower incidence of nephrotic range proteinuria (48% vs. 66%; P = 0.007) and nephrotic syndrome (5.6% vs. 54%; P < 0.001), with higher serum albumin (3.9 vs. 2.9 g/dL; P < 0.001), lower serum cholesterol (229 vs. 335 mg/dL; P < 0.001), and less edema (35% vs. 68%; P = 0.003). On renal biopsy, patients with ORG had fewer lesions of segmental sclerosis (10 vs. 39%; P < 0.001), more glomerulomegaly (100% vs. 10%; P < 0.001), and less extensive foot process effacement (40 vs. 75%; P < 0.001). Glomerular diameter in ORG (mean 226 mu) was significantly larger than age- and sex-matched normal controls (mean 168 mu; P < 0.001). Follow-up was available in 56 ORG patients (mean 27 months) and 50 idiopathic FSGS controls (mean 38 months). A total of 75% of ORG patients received angiotensin-converting enzyme (ACE) inhibition or A2 blockade while 78% of the I-FSGS patients received immunosuppressive therapy. ORG patients had less frequent doubling of serum creatinine (14.3% vs. 50%; P < 0.001) and progression to ESRD (3.6% vs. 42%; P < 0.001). On multivariate analysis, presenting serum creatinine and severity of proteinuria were the only predictors of poor outcome in ORG.ORG is distinct from idiopathic FSGS, with a lower incidence of nephrotic syndrome, more indolent course, consistent presence of glomerulomegaly, and milder foot process fusion. The ten-fold increase in incidence over 15 years suggests a newly emerging epidemic. Heightened physician awareness of this entity is needed to ensure accurate diagnosis and appropriate therapy." @default.
• W2016366089 created "2016-06-24" @default.
• W2016366089 creator A5004877715 @default.
• W2016366089 creator A5015602516 @default.
• W2016366089 creator A5025494644 @default.
• W2016366089 creator A5046194391 @default.
• W2016366089 creator A5067360819 @default.
• W2016366089 date "2001-04-01" @default.
• W2016366089 modified "2023-10-16" @default.
• W2016366089 title "Obesity-related glomerulopathy: An emerging epidemic" @default.
• W2016366089 cites W12554373 @default.
• W2016366089 cites W1684647427 @default.
• W2016366089 cites W1826211555 @default.
• W2016366089 cites W1967457932 @default.
• W2016366089 cites W1967902501 @default.
• W2016366089 cites W1970394955 @default.
• W2016366089 cites W1973464824 @default.
• W2016366089 cites W1980329075 @default.
• W2016366089 cites W1985514124 @default.
• W2016366089 cites W2000824730 @default.
• W2016366089 cites W2002730863 @default.
• W2016366089 cites W2005605175 @default.
• W2016366089 cites W2012277865 @default.
• W2016366089 cites W2013817786 @default.
• W2016366089 cites W2014444848 @default.
• W2016366089 cites W2026414289 @default.
• W2016366089 cites W2032770203 @default.
• W2016366089 cites W2036703449 @default.
• W2016366089 cites W2038261057 @default.
• W2016366089 cites W2050359523 @default.
• W2016366089 cites W2056342151 @default.
• W2016366089 cites W2057142373 @default.
• W2016366089 cites W2064527042 @default.
• W2016366089 cites W2067499664 @default.
• W2016366089 cites W2068472827 @default.
• W2016366089 cites W2071311762 @default.
• W2016366089 cites W2078021044 @default.
• W2016366089 cites W2084497043 @default.
• W2016366089 cites W2085509335 @default.
• W2016366089 cites W2088283855 @default.
• W2016366089 cites W2098330388 @default.
• W2016366089 cites W2109938153 @default.
• W2016366089 cites W2114519559 @default.
• W2016366089 cites W2119269572 @default.
• W2016366089 cites W2121376459 @default.
• W2016366089 cites W2144234891 @default.
• W2016366089 cites W2155083990 @default.
• W2016366089 cites W2293035635 @default.
• W2016366089 cites W2335449614 @default.
• W2016366089 cites W2408913104 @default.
• W2016366089 cites W4250326608 @default.
• W2016366089 doi "https://doi.org/10.1046/j.1523-1755.2001.0590041498.x" @default.
• W2016366089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11260414" @default.
• W2016366089 hasPublicationYear "2001" @default.
• W2016366089 type Work @default.
• W2016366089 sameAs 2016366089 @default.
• W2016366089 citedByCount "1088" @default.
• W2016366089 countsByYear W20163660892012 @default.
• W2016366089 countsByYear W20163660892013 @default.
• W2016366089 countsByYear W20163660892014 @default.
• W2016366089 countsByYear W20163660892015 @default.
• W2016366089 countsByYear W20163660892016 @default.
• W2016366089 countsByYear W20163660892017 @default.
• W2016366089 countsByYear W20163660892018 @default.
• W2016366089 countsByYear W20163660892019 @default.
• W2016366089 countsByYear W20163660892020 @default.
• W2016366089 countsByYear W20163660892021 @default.
• W2016366089 countsByYear W20163660892022 @default.
• W2016366089 countsByYear W20163660892023 @default.
• W2016366089 crossrefType "journal-article" @default.
• W2016366089 hasAuthorship W2016366089A5004877715 @default.
• W2016366089 hasAuthorship W2016366089A5015602516 @default.
• W2016366089 hasAuthorship W2016366089A5025494644 @default.
• W2016366089 hasAuthorship W2016366089A5046194391 @default.
• W2016366089 hasAuthorship W2016366089A5067360819 @default.
• W2016366089 hasBestOaLocation W20163660891 @default.
• W2016366089 hasConcept C120665830 @default.
• W2016366089 hasConcept C121332964 @default.
• W2016366089 hasConcept C126322002 @default.
• W2016366089 hasConcept C126894567 @default.
• W2016366089 hasConcept C134018914 @default.
• W2016366089 hasConcept C2775934546 @default.
• W2016366089 hasConcept C2777390665 @default.
• W2016366089 hasConcept C2778415529 @default.
• W2016366089 hasConcept C2778930706 @default.
• W2016366089 hasConcept C2779561371 @default.
• W2016366089 hasConcept C2780091579 @default.
• W2016366089 hasConcept C2780199430 @default.
• W2016366089 hasConcept C2781087799 @default.
• W2016366089 hasConcept C61511704 @default.
• W2016366089 hasConcept C71924100 @default.
• W2016366089 hasConcept C90924648 @default.
• W2016366089 hasConceptScore W2016366089C120665830 @default.
• W2016366089 hasConceptScore W2016366089C121332964 @default.
• W2016366089 hasConceptScore W2016366089C126322002 @default.
• W2016366089 hasConceptScore W2016366089C126894567 @default.
• W2016366089 hasConceptScore W2016366089C134018914 @default.
• W2016366089 hasConceptScore W2016366089C2775934546 @default.

• next